Step by Stepa HemeOncBuddy patient portal

Bosutinib

Illustration: Bosutinib

Say it: boh-SOO-tih-nib · Brand names: Bosulif

Bosutinib is a targeted pill that blocks the abnormal protein that drives chronic myeloid leukemia.

What it is

In chronic myeloid leukemia, two genes join to make an abnormal protein called BCR-ABL. It tells blood cells to grow out of control. Bosutinib blocks BCR-ABL.

Often used for

How you get it

It is taken by mouth once a day with food. It comes as a pill or a capsule. Many people take it for years. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Bosutinib?
Bosutinib is a targeted pill that blocks the abnormal protein that drives chronic myeloid leukemia. Brand names: Bosulif.
What is Bosutinib used for?
chronic myeloid leukemia (CML) with the Philadelphia chromosome, in adults and children.
How is Bosutinib given?
It is taken by mouth once a day with food. It comes as a pill or a capsule. Many people take it for years. Your schedule may be different.
What are the common side effects of Bosutinib?
Diarrhea, often in the first weeks. Nausea and vomiting. Belly pain. Rash. Feeling tired. Changes in liver blood tests. Low blood counts, found on blood tests.
When should I call my care team while taking Bosutinib?
Diarrhea that does not get better with the medicine your team told you to use, or 4 or more extra stools a day; Vomiting that will not stop, or you cannot keep fluids down; Yellow skin or eyes, dark urine, or pain on the right side of your belly; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, chills, or other signs of infection; Bleeding that will not stop, black or bloody stools, or coughing up blood; Fast weight gain, swelling, or shortness of breath.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.